• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见痴呆症的磁共振波谱分析。

Magnetic resonance spectroscopy in common dementias.

机构信息

Division of Neuroradiology, Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Neuroimaging Clin N Am. 2013 Aug;23(3):393-406. doi: 10.1016/j.nic.2012.10.004. Epub 2013 Feb 27.

DOI:10.1016/j.nic.2012.10.004
PMID:23928196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3748940/
Abstract

Neurodegenerative dementias are characterized by elevated myoinositol and decreased N-acetylaspartate (NAA) levels. The increase in myoinositol seems to precede decreasing NAA levels in Alzheimer's diseases. NAA/myo-inositol ratio in the posterior cingulate gyri decreases with increasing burden of Alzheimer's disease pathologic conditions. Proton magnetic resonance spectroscopy ((1)H MRS) is sensitive to the pathophysiologic processes associated with the risk of dementia in patients with mild cognitive impairment. Although significant progress has been made in improving the acquisition and analysis techniques in (1)H MRS, translation of these technical developments to clinical practice have not been effective because of the lack of standardization for multisite applications and normative data and an insufficient understanding of the pathologic basis of (1)H MRS metabolite changes.

摘要

神经退行性痴呆的特征是肌醇水平升高和 N-乙酰天冬氨酸(NAA)水平降低。肌醇的增加似乎先于阿尔茨海默病中 NAA 水平的降低。在后扣带回皮层,阿尔茨海默病病理状态的负担增加,NAA/肌醇比值降低。质子磁共振波谱(1H MRS)对与轻度认知障碍患者痴呆风险相关的病理生理过程敏感。尽管在提高 1H MRS 的采集和分析技术方面取得了重大进展,但由于缺乏多站点应用和规范数据的标准化以及对 1H MRS 代谢物变化病理基础的理解不足,这些技术发展尚未有效地转化为临床实践。

相似文献

1
Magnetic resonance spectroscopy in common dementias.常见痴呆症的磁共振波谱分析。
Neuroimaging Clin N Am. 2013 Aug;23(3):393-406. doi: 10.1016/j.nic.2012.10.004. Epub 2013 Feb 27.
2
Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.基于社区调查的磁共振波谱在痴呆、阿尔茨海默病和轻度认知障碍检测中的性能
Dement Geriatr Cogn Disord. 2008;26(1):15-25. doi: 10.1159/000140624. Epub 2008 Jun 20.
3
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.认知障碍:采用脑磁共振成像和质子磁共振波谱进行评估
J Clin Psychiatry. 2003 Mar;64(3):235-42. doi: 10.4088/jcp.v64n0303.
4
1H MR spectroscopy in common dementias.常见痴呆症中的氢质子磁共振波谱分析
Neurology. 2004 Oct 26;63(8):1393-8. doi: 10.1212/01.wnl.0000141849.21256.ac.
5
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.在临床环境中,后扣带回皮质中的代谢物比率与帕金森病的认知衰退无关。
Parkinsonism Relat Disord. 2016 Jan;22:54-61. doi: 10.1016/j.parkreldis.2015.11.008. Epub 2015 Nov 12.
6
Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.通过质子磁共振波谱检测早期阿尔茨海默病神经病理学
J Neurosci. 2014 Dec 3;34(49):16247-55. doi: 10.1523/JNEUROSCI.2027-14.2014.
7
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.磁共振波谱分析预测轻度认知障碍向痴呆的转化。
J Neurol Sci. 2013 Dec 15;335(1-2):58-63. doi: 10.1016/j.jns.2013.08.023. Epub 2013 Aug 27.
8
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.阿尔茨海默病颞叶的体内质子磁共振波谱分析
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013.
9
(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.(1)唐氏综合征成人的氢质子磁共振波谱代谢物:痴呆的影响。
Neuroimage Clin. 2016 Jun 2;11:728-735. doi: 10.1016/j.nicl.2016.06.001. eCollection 2016.
10
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.磁共振波谱显示后扣带回皮质 N-乙酰天门冬氨酸/肌醇比值降低可能是临床前阿尔茨海默病的风险标志物之一:一项 7 年随访研究。
J Alzheimers Dis. 2017;60(4):1411-1427. doi: 10.3233/JAD-170450.

引用本文的文献

1
Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.磁共振波谱分析(MRS)在阿尔茨海默病中的应用。
Methods Mol Biol. 2024;2785:115-142. doi: 10.1007/978-1-0716-3774-6_9.
2
Preservation of thalamic neuronal function may be a prerequisite for pain perception in diabetic neuropathy: A magnetic resonance spectroscopy study.丘脑神经元功能的保留可能是糖尿病性神经病变中疼痛感知的一个先决条件:一项磁共振波谱研究。
Front Pain Res (Lausanne). 2023 Jan 6;3:1086887. doi: 10.3389/fpain.2022.1086887. eCollection 2022.
3
Diffusion tension imaging is a good tool for assessing patients with dementia and behavioral problems and discriminating them from other dementia patients.扩散张力成像对于评估患有痴呆症和行为问题的患者并将他们与其他痴呆症患者区分开来是一种很好的工具。
Acta Radiol Open. 2021 Dec 17;10(12):20584601211066467. doi: 10.1177/20584601211066467. eCollection 2021 Dec.
4
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.具有中枢神经系统穿透性的可溶性鸟苷酸环化酶刺激剂CY6463揭示了其在神经退行性疾病中的治疗潜力。
Front Pharmacol. 2021 May 24;12:656561. doi: 10.3389/fphar.2021.656561. eCollection 2021.
5
Clinical and radiological aspects of bilateral temporal abnormalities: pictorial essay.双侧颞叶异常的临床与影像学表现:图文综述
Radiol Bras. 2021 Mar-Apr;54(2):115-122. doi: 10.1590/0100-3984.2019.0134.
6
-Acetylaspartyl-Glutamate Metabolism in the Cingulated Cortices as a Biomarker of the Etiology in ASD: A H-MRS Model.扣带回皮质中的乙酰天门冬氨酸-谷氨酸代谢作为 ASD 病因的生物标志物:一项 H-MRS 模型研究。
Molecules. 2021 Jan 28;26(3):675. doi: 10.3390/molecules26030675.
7
Application of H-MRS in end-stage renal disease with depression.H-MRS 在伴有抑郁的终末期肾病中的应用。
BMC Nephrol. 2020 Jun 15;21(1):225. doi: 10.1186/s12882-020-01863-0.
8
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration.症状前家族性额颞叶痴呆神经退行性变的影像学生物标志物
Front Neurol. 2020 Feb 28;11:80. doi: 10.3389/fneur.2020.00080. eCollection 2020.
9
Frontal lobe H MR spectroscopy in asymptomatic and symptomatic mutation carriers.额叶 H 磁共振波谱在无症状和有症状突变携带者中的研究。
Neurology. 2019 Aug 20;93(8):e758-e765. doi: 10.1212/WNL.0000000000007961. Epub 2019 Jul 17.
10
Metabolite Profile of Alzheimer's Disease in the Frontal Cortex as Analyzed by HRMAS H NMR.通过高分辨魔角旋转氢核磁共振波谱分析的额叶皮质中阿尔茨海默病的代谢物谱
Front Aging Neurosci. 2019 Jan 9;10:424. doi: 10.3389/fnagi.2018.00424. eCollection 2018.

本文引用的文献

1
Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies.MRI 上的局灶性萎缩与路易体痴呆的神经病理学分类。
Neurology. 2012 Aug 7;79(6):553-60. doi: 10.1212/WNL.0b013e31826357a5. Epub 2012 Jul 25.
2
The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.通过质子磁共振波谱测量发现,阿尔茨海默病和皮质下缺血性血管性痴呆的海马代谢物特征不同。
J Cereb Blood Flow Metab. 2012 May;32(5):805-15. doi: 10.1038/jcbfm.2012.9. Epub 2012 Feb 8.
3
Testing the right target and right drug at the right stage.在恰当的阶段针对恰当的靶点和药物进行检测。
Sci Transl Med. 2011 Nov 30;3(111):111cm33. doi: 10.1126/scitranslmed.3002609.
4
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease.磁共振成像和磁共振波谱在早期阿尔茨海默病检测中的应用。
J Alzheimers Dis. 2011;26 Suppl 3:307-19. doi: 10.3233/JAD-2011-0028.
5
Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study.微创生物标志物证实阿尔茨海默病中存在神经胶质激活:一项初步研究。
Neuropsychiatr Dis Treat. 2011;7:495-9. doi: 10.2147/NDT.S23721. Epub 2011 Aug 24.
6
Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.基于人群的认知正常老年人队列中磁共振波谱、β-淀粉样蛋白负荷与认知的关系
Neurology. 2011 Sep 6;77(10):951-8. doi: 10.1212/WNL.0b013e31822dc7e1. Epub 2011 Aug 24.
7
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致痴呆的诊断:美国国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议。
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
8
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致轻度认知障碍的诊断:美国国家老龄化研究所-阿尔茨海默病协会诊断指南工作组的建议。
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
9
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.为了定义阿尔茨海默病的临床前阶段:来自美国国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议。
Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.
10
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议简介。
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.